Flavr Savr (also known as CGN-89564-2; pronounced "flavor saver"), a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption.

The genetically modified tomato went to U.S. market on May 21, 1994 known as the Flavr Savr. This transgenic tomato was no longer able to produce polygalacturonase(PG), which is an enzyme involved in

2021年7月4日 · The very first genetically modified food that was introduced into the market was a tomato called Flavr Savr. It was when Calgene, a California company, submitted the necessary documents for evaluation by the U.S. Food and Drug Administration (FDA) in 1992.

delayed fruit softening genetically modified tomato FLAVR SAVR TM 所属学科 植物保护学

2021年9月23日 · 自1994年，世界所公认的第一种获得消费许可的商业种植的转基因作物——美国加尔金公司发布的番茄（Flavr Savr番茄）、到次年（1995年），美国又发布抗虫害功能的马铃薯，再到孟加拉国有望成为全球第一个种植转基因黄金大米的国家、阿根廷政府2020年10月9日 ...

2017年11月21日 · 1994 年，美国 Calgene 公司研发的转基因耐贮番茄 FLAVR SAVR 被批准在美国上市，成为全球首例商业化生产的 转基因作物。 FLAVR SAVR 的研发思路是通过调控多聚半乳糖醛酸酶的表达，延迟番茄软化过程，从而延长其货架寿命，达到耐贮藏的目的。

2013年5月6日 · The FDA approved the sale of the first genetically modified food - the FLAVR SAVR tomato, deeming it as safe as conventionally-bred tomatoes. The FDA's decision on the FLAVR SAVR tomato - marketed by Calgene, Inc. of Davis, California - marked the first time the agency evaluated a food that was genetically engineered.

After over a decade of research, Calgene perfected the Flavr Savr, their genetically engineered tomato. The scientists have altered the gene on the tomato that cause softening so that farmers can allow the tomato to stay on the vine for a few days longer than regular supermarket tomatoes which are picked when they are green and later exposed to ...

1994年4月1日 · This article provides a case study of the FLAVR SAVR☆m tomato as a demonstration of the regulatory procedures and safety assessment necessary in the USA.

The Flavr Savr tomato was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration (FDA) in 1992.